Starling Oncology, Inc. Common Stock (STLN) Stock Price
STLNStock
$6.43
Market Cap$655.32M
P/E—
PEG Ratio—
Div yield—
Beta2.42
STLN Share Price Chart
Favorite Metrics
Price vs S&P 500 (4W)-4.53%
VGM Score42.02
STLN Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | -$0.06 | -$0.08 | -25.00%(-$0.02) | |
| Q1 2026 | -$0.09 | -$0.02 | +77.14%(+$0.07) | |
| Q4 2025 | -$0.09 | -$0.06 | +33.33%(+$0.03) | |
| Q3 2025 | -$0.11 | -$0.14 | -23.53%(-$0.03) | |
| Q2 2025 | -$0.12 | -$0.15 | -25.00%(-$0.03) |
STLN Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.20
4.20
4.18
4.18
Industry Peers — Physicians' Offices(15)
| Symbol | Value Score | Growth Score | Momentum Score | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
STLNStarling Oncology, Inc. Common Stock | F | A | D | — | 38.4% | -4.4% | -482.6% | $6.43 |
| HIMSHims & Hers Health, Inc. | D | B | D | 51.0x | 28.0% | -6.0% | -30.0% | $28.07 |
| TDOCTeladoc Health, Inc. | A | C | D | — | -2.1% | -7.5% | -13.1% | $5.67 |
| TOIThe Oncology Institute, Inc. Common Stock | D | A | A | — | 35.4% | -6.0% | -482.6% | $7.05 |
| SBCSBC Medical Group Holdings Incorporated Common Stock | B | C | B | 10.4x | -6.9% | 37.3% | 19.3% | $5.16 |
| AUNAAuna S.A. | A | D | C | 13.9x | 7.8% | 13.4% | 0.9% | $5.32 |
| LFMDLifeMD, Inc. Common Stock | C | C | F | 7.9x | -16.7% | -12.4% | 1.7% | $2.34 |
| AIRSAirSculpt Technologies, Inc. Common Stock | C | F | F | — | -8.7% | -8.3% | -12.5% | $1.27 |
| WSTNWestin Acquisition Corp Class A Ordinary Share | — | — | C | — | — | — | — | $10.21 |
| CCMConcord Medical Services Holding Limited | B | A | D | — | 40.1% | -45.0% | -11.6% | $3.63 |
| BMGLBasel Medical Group Ltd Ordinary Shares | C | A | D | — | 29.8% | -55.9% | -178.8% | $3.95 |
About Starling Oncology, Inc. Common Stock
Starling Oncology Inc provides oncology care services in community settings. Its services include cancer diagnosis and treatment, clinical trials, transfusion services, and other oncology care delivery models for patients.